Last Updated:
January 30th, 2026
Iboga addiction: Signs, symptoms and side-effects
Iboga is a shrub from Central Africa with root bark containing ibogaine, an extremely powerful psychoactive substance. Iboga is traditionally used in Bwiti spiritual practices, but is sometimes used as an alternative addiction treatment. Use in the UK is thought to be exceptionally rare, with no reliable statistics available. However, what is known is that ibogaine carries serious cardiac risks, and psychological addiction can develop without any physical dependence. Recognising the signs of iboga addiction is crucial as it can prevent the dangers spiralling and could even save your life.

What is iboga addiction?
Iboga addiction is a rare but serious condition that develops when repeated use becomes a pattern you can’t break despite knowing the risks you are taking. The rarity of iboga addiction in Britain doesn’t diminish the dangers, however, especially for individuals and communities more likely to use it.
It can be a particularly cruel addiction as some people become dependent on a substance they originally used to break free from other substance use disorders. This is partly why iboga addiction often goes unrecognised, as users see it as medical treatment rather than drug-taking.
How does iboga addiction develop?
Iboga addiction follows an unusual path because people often first use it to address other forms of drug addiction or sometimes mental health issues. The progression typically looks something like this:
Iboga abuse
Your first iboga experience may be in a treatment setting or through someone offering it as a solution to addiction or depression. The effects are intensely powerful, with vivid visions, emotional release, and sometimes temporary relief from cravings or mental health symptoms. If you credit these effects with recovery or breakthrough, it is only natural to continue using.
Iboga dependence
As a single treatment session becomes something you repeat, iboga can become your answer to emotional, spiritual, or substance-related issues. Between iboga sessions, ordinary challenges can feel impossible to manage, and you can become convinced it is the only solution available.
Iboga addiction
Once addicted, iboga misuse can become impossible to resist despite growing concerns you are starting to have. You may begin to experience some of the symptoms of addiction explained below, but you carry on using iboga regardless.
How to identify iboga addiction signs
Overcoming iboga addiction denial is difficult because many people see it as medical treatment, not drug use. Iboga sessions are also infrequent compared to other substance use, and with sessions sometimes weeks or months apart, it can be harder to spot these iboga addiction signs:
- Using iboga far more often than the single or occasional “treatment” you originally decided to try.
- Believing iboga creates breakthroughs, but struggling to sustain any progress between sessions.
- Travelling abroad or spending large amounts of money on iboga, even when that hurts your finances or relationships.
- Using iboga despite experiencing dangerous heart symptoms like severe palpitations or chest pain.
- Using iboga every time you’re struggling emotionally, rather than therapy or seeking other support.
- Hiding your iboga use from doctors or family because you know they would be concerned.
Why is iboga addictive?
Ibogaine affects numerous brain systems at once, producing effects lasting 24-36 hours. The experience often involves reviewing your entire life and accessing buried memories, and when this intensity fades, daily life can feel empty in comparison.
But it is also a mixture of specific personal circumstances that increase the chances of developing an iboga addiction:
Iboga side effects and addiction risks
Iboga is significantly more dangerous physically than other psychedelics. Multiple deaths have occurred even in supervised settings, making repeated use exceptionally risky:
What does iboga addiction recovery involve?
Getting help for iboga addiction requires specialists who understand both the psychological patterns and the serious medical risks involved. There are three main phases to effective treatment:
1. Drug detox
A medically-assisted detox first removes iboga from your system, addresses any lingering physical effects, and possibly checks for iboga-related heart or psychological damage.
2. Drug rehab
Inpatient rehab treatment is then best for tackling why you became dependent on such a dangerous substance. It may include trauma therapy to address underlying PTSD, relapse prevention planning, and other evidence-based therapies to work through your underlying personal needs.
3. Post-rehab recovery
Long-term recovery may include a mixture of aftercare services provided by your rehab centre and local support you access on your own. This can include NA meetings, 12-step groups, and therapy for emotional and mental health struggles.
Not sure where to turn? Recovery.org connects people throughout Britain with treatment centres equipped to handle complex addiction cases. Contact us today to discuss your situation confidentially and learn more about the rehab programmes available to you.
Frequently Asked Questions
(Click here to see works cited)
- Corkery, John M. “Ibogaine as a Treatment for Substance Misuse: Potential Benefits and Practical Dangers.” Progress in Brain Research, vol. 242, 2018, pp. 217-257, https://www.sciencedirect.com/science/article/abs/pii/S0079612318300979
- DrugWise. “Ibogaine.” DrugWise, 2016,
https://www.drugwise.org.uk/ibogaine/ - Koenig, Xaver, and Karlheinz Hilber. “The Anti-Addiction Drug Ibogaine and the Heart: A Delicate Relation.” Molecules, vol. 20, no. 2, 2015, pp. 2208-2228, https://doi.org/10.3390/molecules20022208
- Ndoua, Pierre Didier Nyongo, and Kaveh Vaghar. “Bwiti, Iboga, Trance and Healing in Gabon.” Mental Health, Religion & Culture, vol. 21, no. 8, 2018, pp. 755-762, https://doi.org/10.1080/13674676.2018.1504012
- Williams, Nolan R., et al. “Magnesium–Ibogaine Therapy in Veterans with Traumatic Brain Injuries.” Nature Medicine, vol. 30, 2024, pp. 373-381, https://doi.org/10.1038/s41591-023-02705-w

